- Home
- VHC vs SER Comparison
VHC vs SER Comparison
Compare VHC & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VHC
- SER
- Stock Information
- Founded
- VHC 2005
- SER 2017
- Country
- VHC United States
- SER United States
- Employees
- VHC N/A
- SER N/A
- Industry
- VHC Multi-Sector Companies
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- VHC Miscellaneous
- SER Health Care
- Exchange
- VHC Nasdaq
- SER Nasdaq
- Market Cap
- VHC 48.2M
- SER 56.5M
- IPO Year
- VHC 1999
- SER 2018
- Fundamental
- Price
- VHC $18.46
- SER $5.40
- Analyst Decision
- VHC
- SER Strong Buy
- Analyst Count
- VHC 0
- SER 2
- Target Price
- VHC N/A
- SER $13.00
- AVG Volume (30 Days)
- VHC 28.3K
- SER 23.9K
- Earning Date
- VHC 08-13-2025
- SER 08-08-2025
- Dividend Yield
- VHC N/A
- SER N/A
- EPS Growth
- VHC N/A
- SER N/A
- EPS
- VHC N/A
- SER N/A
- Revenue
- VHC $3,000.00
- SER $51,000.00
- Revenue This Year
- VHC N/A
- SER N/A
- Revenue Next Year
- VHC N/A
- SER N/A
- P/E Ratio
- VHC N/A
- SER N/A
- Revenue Growth
- VHC N/A
- SER N/A
- 52 Week Low
- VHC $3.68
- SER $3.81
- 52 Week High
- VHC $21.53
- SER $11.57
- Technical
- Relative Strength Index (RSI)
- VHC 66.57
- SER 45.42
- Support Level
- VHC $18.07
- SER $5.11
- Resistance Level
- VHC $21.53
- SER $5.67
- Average True Range (ATR)
- VHC 2.12
- SER 0.38
- MACD
- VHC 0.13
- SER -0.01
- Stochastic Oscillator
- VHC 68.90
- SER 38.52
About VHC VirnetX Holding Corp
VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.